Skip to main content
Madison Conces, MD, Oncology, Cleveland, OH

Madison Conces MD

Gastrointestinal Cancer


Physician

Join to View Full Profile
  • 11100 Euclid AveCleveland, OH 44106

Dr. Conces is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Summary

  • Madison Conces, MD, is an oncologist based in Cleveland, OH, specializing in gastrointestinal cancer. She completed her medical education at Indiana University School of Medicine in 2017 and pursued a residency in Internal Medicine, followed by a fellowship in Hematology and Medical Oncology at Cleveland Clinic Foundation. Dr. Conces has been working at University Hospital Seidman Cancer Center Physicians and serves as an Assistant Professor at Case Western Reserve University School of Medicine since 2023. Her recent publications cover diverse topics within colorectal cancer, including host-microbiome interactions and predictive indicators in therapeutic settings, and have been featured in notable journals like NPJ Precision Oncology and Annals of Surgical Oncology.

Education & Training

  • Cleveland Clinic Foundation
    Cleveland Clinic FoundationFellowship, Hematology and Medical Oncology, 2020 - 2023
  • Cleveland Clinic Foundation
    Cleveland Clinic FoundationResidency, Internal Medicine, 2017 - 2020
  • Indiana University School of Medicine
    Indiana University School of MedicineClass of 2017

Certifications & Licensure

  • OH State Medical License
    OH State Medical License 2017 - 2027
  • Internal Medicine
    American Board of Internal Medicine Internal Medicine
  • Medical Oncology
    American Board of Internal Medicine Medical Oncology

Publications & Presentations

PubMed

Lectures

  • Clonal hematopoiesis of indeterminate potential (CHIP) mutations in solid tumor malignancies. 
    2019 ASCO Annual Meeting - 6/1/2019

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: